Scarsi KK, Fehintola FA, Ma Q, Aweeka FT, Darin KM, Morse GD, Akinola IT, Adedeji WA, Lindegardh N, Tarning J, Ojengbede O, Adewole IF, Taiwo B, Murphy RL, Akinyinka OO and Parikh S: Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. J Antimicrob Chemother. 2014 May;69 (5) :1370-6. Epub 2014 Jan 19. PMID: 24446424

Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR and Stewart VA: Malaria diagnostics in clinical trials. Am J Trop Med Hyg. 2013 Nov;89 (5) :824-39. Epub 2013 Sep 23. PMID: 24062484

Gong L, Parikh S, Rosenthal PJ and Greenhouse B: Biochemical and immunological mechanisms by which sickle cell trait protects against malaria. Malar J. 2013 Sep 11;12 :317. Epub 2013 Sep 11. PMID: 24025776

Creek DJ, Bigira V, McCormack S, Arinaitwe E, Wanzira H, Kakuru A, Tappero JW, Sandison TG, Lindegardh N, Nosten F, Aweeka FT and Parikh S: Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants. J Infect Dis. 2013 Jun 1;207 (11) :1646-54. Epub 2013 Feb 27. PMID: 23447696

Huang L, Parikh S, Rosenthal PJ, Lizak P, Marzan F, Dorsey G, Havlir D and Aweeka FT: Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers. J Acquir Immune Defic Syndr. 2012 Nov 1;61 (3) :310-6. PMID: 22918158

Lee TM, Huang L, Johnson MK, Lizak P, Kroetz D, Aweeka F and Parikh S: In vitro metabolism of piperaquine is primarily mediated by CYP3A4. Xenobiotica. 2012 Nov;42 (11) :1088-95. Epub 2012 Jun 6. PMID: 22671777

Fehintola FA, Scarsi KK, Ma Q, Parikh S, Morse GD, Taiwo B, Akinola IT, Adewole IF, Lindegardh N, Phakderaj A, Ojengbede O, Murphy RL, Akinyinka OO and Aweeka FT: Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults. AIDS Res Treat. 2012;2012 :703604. Epub 2012 Mar 5. PMID: 22500218

Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, Clark TD, Dorsey G, Lindegardh N, Annerberg A, Rosenthal PJ, Kamya MR and Aweeka F: Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother. 2010 Jan;54 (1) :52-9. Epub 2009 Oct 19. PMID: 19841149

Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ and Parikh S: Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PLoS One. 2009 Sep 30;4 (9) :e7246. Epub 2009 Sep 30. PMID: 19789650

German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N and Aweeka FT: Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. J Acquir Immune Defic Syndr. 2009 Aug 1;51 (4) :424-9. PMID: 19506482